{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:28:49Z","timestamp":1791426529005,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejps.2022.106260","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T02:10:14Z","timestamp":1657678214000},"page":"106260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Biopredictive capability assessment of two dissolution\/permeation assays, \u00b5FLUX\u2122 and PermeaLoop\u2122, using supersaturating formulations of Posaconazole"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-1095","authenticated-orcid":false,"given":"Florentin Lukas","family":"Holzem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Weck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine Petrig","family":"Schaffland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Stillhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-6984","authenticated-orcid":false,"given":"Annette","family":"Bauer-Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106260_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0002","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpb.2012.07.009","article-title":"Drug precipitation-permeation interplay: supersaturation in an absorptive environment","volume":"82","author":"Bevernage","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2022.106260_bib0003","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105532","article-title":"Dissolution\/permeation with PermeaLoop: experience and IVIVC exemplified by dipyridamole enabling formulations","volume":"154","author":"Eriksen","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2018.01.039","article-title":"Evaluation and optimized selection of supersaturating drug delivery systems of Posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in vitro-in silico-in vivo approach","volume":"115","author":"Hens","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0006","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/jps.24690","article-title":"Supersaturation and precipitation of posaconazole upon entry in the upper small intestine in humans","volume":"105","author":"HENS","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0007","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.xphs.2016.03.027","article-title":"Gastrointestinal and systemic monitoring of posaconazole in humans after fasted and fed state administration of a solid dispersion","volume":"105","author":"HENS","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106166","article-title":"Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid- associated drug concentrations during biomimetic dissolution testing of supersaturating formulations","author":"Holzem","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12248-018-0231-8","article-title":"The BioGIT system: a valuable in vitro tool to assess the impact of dose and formulation on early exposure to low solubility drugs after oral administration","volume":"20","author":"Kourentas","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2022.106260_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejps.2015.11.012","article-title":"An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation","volume":"82","author":"Kourentas","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0011","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1021\/acs.molpharmaceut.5b00135","article-title":"In Vitro dissolution of fluconazole and dipyridamole in gastrointestinal simulator (GIS), predicting in vivo dissolution and drug\u2013drug interaction caused by acid-reducing agents","volume":"12","author":"Matsui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2022.106260_bib0012","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/mp500196f","article-title":"Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum","volume":"11","author":"Mitra","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2022.106260_bib0013","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/bdd.1803","article-title":"Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus","volume":"33","author":"Mudie","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2022.106260_bib0014","article-title":"Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review","author":"O\u2019shea","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106260_bib0015","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11095-012-0844-z","article-title":"An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine","volume":"29","author":"Psachoulias","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106260_bib0016","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1021\/acs.molpharmaceut.9b00799","article-title":"Application of the GastroDuo as an in vitro dissolution tool to simulate the gastric emptying of the postprandial stomach","volume":"16","author":"Schick","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2022.106260_bib0017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2017.03.002","article-title":"Evaluation of a dynamic dissolution\/permeation model: mutual influence of dissolution and barrier-flux under non-steady state conditions","volume":"522","author":"Sironi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106260_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpba.2018.04.042","article-title":"PermeaLoop, a novel in vitro tool for small-scale drug-dissolution\/permeation studies","volume":"156","author":"Sironi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2022.106260_bib0019","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11095-018-2440-3","article-title":"Ranking itraconazole formulations based on the flux through artificial lipophilic membrane","volume":"35","author":"Tsinman","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106260_bib0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","article-title":"Effect of pH and comedication on gastrointestinal absorption of Posaconazole","volume":"50","author":"Walravens","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2022.106260_bib0021","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1208\/s12248-016-9972-4","article-title":"Utilizing in vitro dissolution-permeation chamber for the quantitative prediction of pH-dependent drug-drug interactions with acid-reducing agents: a comparison with physiologically based pharmacokinetic modeling","volume":"18","author":"Zhu","year":"2016","journal-title":"AAPS J."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:04:15Z","timestamp":1760529855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":21,"alternative-id":["S0928098722001452"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106260","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopredictive capability assessment of two dissolution\/permeation assays, \u00b5FLUX\u2122 and PermeaLoop\u2122, using supersaturating formulations of Posaconazole","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106260"}}